Andere Kunden interessierten sich auch für
![Novel Drug Delivery Technologies for Vaginal Afflictions]( "Novel Drug Delivery Technologies for Vaginal Afflictions")
Novel Drug Delivery Technologies for Vaginal Afflictions48,99 €![Vaginal Drug Delivery System]( "Vaginal Drug Delivery System")
Vaginal Drug Delivery System26,99 €![Development Of Herbal Vaginal Gel Formulation And Technology]( "Development Of Herbal Vaginal Gel Formulation And Technology")
Development Of Herbal Vaginal Gel Formulation And Technology23,99 €![Design, Development and QSAR studies of 1, 2, 4-triazole compounds]( "Design, Development and QSAR studies of 1, 2, 4-triazole compounds")
Design, Development and QSAR studies of 1, 2, 4-triazole compounds39,99 €![Medicinal chemistry of some important anti-infective agents]( "Medicinal chemistry of some important anti-infective agents")
Medicinal chemistry of some important anti-infective agents23,99 €![Antimicrobial activity of Picrorhiza kurroa]( "Antimicrobial activity of Picrorhiza kurroa")
Antimicrobial activity of Picrorhiza kurroa39,99 €![Anti-HIV Bioadhesive Microencapsulated Vaginal Gel]( "Anti-HIV Bioadhesive Microencapsulated Vaginal Gel")
Anti-HIV Bioadhesive Microencapsulated Vaginal Gel51,99 €
Efficient drug delivery at vaginal cavity is often a challenge owing to its peculiar physiological variations including vast differences in pH. Keeping in view this attribute of the target site, the current work was aimed at developing formulation strategies which could overcome this and successfully deliver molecule like Ciclopirox olamine through SLNs. Optimized SLNs was selected for further development into. When evaluated in vivo, it did not exhibit any irritation potential despite appreciable bioadhesion. A remarkable decrease in CFUs was also observed when evaluated in rat infection model. Thus, the proposed study defines the challenges for developing a suitable formulation system overcoming the delivery barriers of the vaginal site.